• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 01931110#QUADROX-I PÄDIATRIC +FILTERED MICRO.SOFT.
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/15/2019
Event Type  malfunction  
Manufacturer Narrative
It was reported by sales unit on (b)(6) 2019 reported two batches regarding complaint # (b)(4) were found during two different cases.Therefore second emdr has been created.A follow-up medwatch will be submitted when additional information becomes available.
 
Event Description
The user ((b)(4)) complains 2 pieces hmo 31000.Lot: 70122866.Lot: 70122025.Following the description of the user: at the arterial outlet connector there is a fine hairline tear in both oxygenators! this became visible after priming the system, which also could not be sealed.The oxy was then exchanged and thus no danger to the patient.Cormed complaint: (b)(4).Complaint: (b)(4).
 
Manufacturer Narrative
Maquet cardiopulmonary gmbh was requested the product back for investigation in the laboratory of manufacturer.Visual inspection and leak test per local procedure lv 201 were performed.In both products, hairline cracks were detected at the blood outlet connector and the luer lock connector on the outlet side.Based on this, failures could be confirmed.Trend search was performed.7 additional complaints were recorded in the last 12 months.The occurrence rate regarding this complaint is below the acceptance criteria.Thus, no remedial action required.Device history record for lot #70122866 was reviewed.There were no references found, which are indicating a nonconformance of the product in question.The reported failure was identified as part of the current risk management file (dms#(b)(4)).Mitigations for this specific failure are in place as per instruction for use warnings and design specifications.The manufacturer`s review of the control form in production indicated that a 100% visual inspection for deformation is conducted during manufacturing.The information obtained so far in this investigation would confirm that the device met its specification at the time of manufacturing and therefore all damages found on the product are due to excessive or inadequate external physical force that was exerted on the product after the release.This complaint is being monitored as part of the complaint data trending of maquet cardiopulmonary gmbh and further investigations and measures will be conducted in case of adverse trending.
 
Event Description
Complaint: #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key9433502
MDR Text Key204926332
Report Number8010762-2019-00385
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K132829
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 01/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number01931110#QUADROX-I PÄDIATRIC +FILTERED MICRO.SOFT.
Device Catalogue Number701048493
Device Lot Number70122866
Initial Date Manufacturer Received 11/12/2019
Initial Date FDA Received12/06/2019
Supplement Dates Manufacturer Received01/28/2020
Supplement Dates FDA Received01/30/2020
Patient Sequence Number1
-
-